| 영문 | taste bud | 한글 | 맛봉오리 |
|---|---|---|---|
| 설명 | 혀를 비롯한 구강 점막의 일부에 분포하는 미각 수용기. 맛신경의 종말기가 되는 작은 구조이다. 꽃봉오리 모양이며, 높이 약80㎛, 너비 약40㎛이다. 입 특히 혀점막의 유두 속에 많이 분포한다. 물렁입천장이나 후두개의 상피 속에서도 흔히 볼 수 있다. 맛봉오리의 대부분을 차지하며 외주부에 있는 것이 지지세포이며 난원형의 핵을 가진다. 내부에 있는 지지세포는 꼿꼿하므로 기둥세포라고도 한다. 미세포는 맛봉오리 내부에 있고 간상이며, 굵은 중간 부분에 핵이 들어 있다. 맛봉오리는 장축을 가지고 점막 상피 안에 들어 있으며, 그 유리 표면에 작은 구멍이 있다. 맛봉오리신경은 혀의 뒤쪽 1/3과 엽상유두에는 혀인두신경으로부터, 혀의 앞 2/3에는 고삭신경에서 온 신경으로 맛봉오리 안에서 끝나는 맛봉오리 내 섬유와 맛봉오리 밖의 상피 내에서 끝나는 맛봉오리 간 섬유로 나뉜다. 맛봉오리가 미각에 관계하는 것은 사실이지만 모든 미각이 맛봉오리에 의존하는 것은 아니다. 타닌 등의 떫은 맛은 혀와 구강점막 전체가 자극되어 일어나는 감각이며, 맛봉오리와는 관계가 없다. |
||
| RES | Reticulo-Endothelial System |
|---|---|
| ARES | antireticulo-endothelial serum |
| BAEC | bovine aortic endothelial cells |
| BPAEC | bovine pulmonary artery endothelial cell |
| EC | effective concentration; ejection click; electrochemical; electron capture; embryonal carcinoma; eme... |
| BUD | Budesonide |
|---|---|
| LB | Limb bud |
| TEB | Terminal end bud |
| UB | ureteric bud |
| ABAE | Adult bovine aortic endothelial |
| vascular endothelial growth factor | A growth factor that is responsible for the growth of blood vessels. (12 Dec 1998) |
|---|---|
| platelet endothelial cell activated protease | <enzyme> Degrades casein and fibrinogen; secreted by endothelial cells and activated in the extracellular medium by platelets; not inhibited by serine protease inhibitors, metalloproteinase inhibitors, or cystein protease inhibitors; pH optimum 7.5 Registry number: EC 3.4.99.- Synonym: pecap (26 Jun 1999) |
| corneal endothelial polymorphism | A greater than normal variation in the shape of the cells. (05 Mar 2000) |
| high endothelial postcapillary venules | Venule's in the lymph nodes, tonsils, and Peyer's patches that have a high-walled endothelium through which blood lymphocytes migrate into the lymphatic parenchyma. (05 Mar 2000) |
| intravascular papillary endothelial hyperplasia | A benign florid papillary endothelial proliferation within the veins of the skin or subcutis, less often in visceral blood vessels. Synonym: Masson's pseudoangiosarcoma. (05 Mar 2000) |
| iridocorneal endothelial syndrome | <syndrome> Syndrome of glaucoma, iris atrophy, decreased corneal endothelium, anterior peripheral synechia, and multiple iris nodules. Synonym: Cogan-Reese syndrome, iris-nevus syndrome. (05 Mar 2000) |
| endothelial | Pertaining to or made up of endothelium. (16 Dec 1997) |
| endothelial cell | A thin, flattened cell, a layer of them lines the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium. (09 Oct 1997) |
| endothelial cyst | A serous cyst whose sac is lined with endothelium. (05 Mar 2000) |
| endothelial dystrophy of cornea | Spontaneous loss of corneal endothelium leading to oedema of the corneal stroma and epithelium. (05 Mar 2000) |
| endothelial growth factors | These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesise DNA. The factors are related to both the basic and acidic fibroblast growth factors but have different amino acid sequences. (12 Dec 1998) |
| endothelial leukocyte | Old term for a monocyte, a type of leukocyte thought to be derived from reticuloendothelial tissue. (05 Mar 2000) |
| endothelial-leukocyte adhesion molecule | 115,000 Mw molecule on the surface of endothelial cells that is involved in blood leukocyte attachment to vessel walls as well as emigration from the vessels into the tissues. (05 Mar 2000) |
| endothelial myeloma | A malignant primary bone tumour that arises most commonly in the first three decades of life. It is highly malignant (prone to spread) and often requires treatment with some combination of radiation therapy and chemotherapy. (27 Sep 1997) |
| endothelial relaxing factor | A molecule functioning as a neurotransmitter and produced by activated macrophages. It is capable of killing tumour cells, parasites, and intracellular bacteria. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|